Search research articles
Contact Us
Filters
Showing results (111-120 of 207) with videos related to
Page
of 21
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
Matthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 13, 2025
Liquid Biopsy of Circulating Tumor Cells and DNA in the Context of PSMA Radiopharmaceutical Therapy
Adrien Holzgreve, Christine E Mona, Koichiro Kimura, et al.
Radiology
|
July 11, 2023
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
Andrei Gafita, Loïc Djaileb, Isabel Rauscher, et al.
The Prostate
|
November 29, 2022
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting
Andrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala, et al.
European Urology
|
March 17, 2024
Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial
John Nikitas, Matthew Rettig, John Shen, et al.
Frontiers in Medicine
|
June 26, 2020
Correlation Between FDG Hotspots on Pre-radiotherapy PET/CT and Areas of HNSCC Local Relapse: Impact of Treatment Position and Images Registration Method
Blandine Truffault, David Bourhis, Anne Chaput, et al.
Scientific Reports
|
October 17, 2024
Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapy
John Nikitas, Andrei Gafita, Matthias R Benz, et al.
EJNMMI Research
|
October 1, 2022
Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225
Catherine Meyer, Vikas Prasad, Andreea Stuparu, et al.
BJU International
|
February 16, 2023
LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol)
Ting Martin Ma, Johannes Czernin, Carol Felix, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2021
The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
Wesley R Armstrong, Andrei Gafita, Shaojun Zhu, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 207) with videos related to
Sort By:
Page
of 21
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 17, 2021
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma
Matthias R Benz, Wesley R Armstrong, Francesco Ceci, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 13, 2025
Liquid Biopsy of Circulating Tumor Cells and DNA in the Context of PSMA Radiopharmaceutical Therapy
Adrien Holzgreve, Christine E Mona, Koichiro Kimura, et al.
Radiology
|
July 11, 2023
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
Andrei Gafita, Loïc Djaileb, Isabel Rauscher, et al.
The Prostate
|
November 29, 2022
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting
Andrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala, et al.
European Urology
|
March 17, 2024
Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial
John Nikitas, Matthew Rettig, John Shen, et al.
Frontiers in Medicine
|
June 26, 2020
Correlation Between FDG Hotspots on Pre-radiotherapy PET/CT and Areas of HNSCC Local Relapse: Impact of Treatment Position and Images Registration Method
Blandine Truffault, David Bourhis, Anne Chaput, et al.
Scientific Reports
|
October 17, 2024
Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapy
John Nikitas, Andrei Gafita, Matthias R Benz, et al.
EJNMMI Research
|
October 1, 2022
Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225
Catherine Meyer, Vikas Prasad, Andreea Stuparu, et al.
BJU International
|
February 16, 2023
LUNAR: a randomized Phase 2 study of <sup>177</sup> Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol)
Ting Martin Ma, Johannes Czernin, Carol Felix, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2021
The Impact of Monosodium Glutamate on <sup>68</sup>Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study
Wesley R Armstrong, Andrei Gafita, Shaojun Zhu, et al.
Page
of 21